Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation

<div>(a) GO analysis of the genes common to Fisetin and NSCLC. (b) KEGG pathway enrichment analysis. (c) The compound-target-disease network. The green diamond represented Fisetin, red square represented NSCLC, and blue circles represented the shared targets.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation 

Figure 3 | Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation 